BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27322606)

  • 1. The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study.
    Nanwa N; Kwong JC; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Sander B
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1068-78. PubMed ID: 27322606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions.
    Nanwa N; Sander B; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Kwong JC
    PLoS One; 2017; 12(3):e0172410. PubMed ID: 28257438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attributable costs and length of stay of hospital-acquired
    Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital-acquired Clostridium difficile infection: an institutional costing analysis.
    Choi KB; Suh KN; Muldoon KA; Roth VR; Forster AJ
    J Hosp Infect; 2019 Jun; 102(2):141-147. PubMed ID: 30690051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
    Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable Cost of Clostridium difficile Infection in Pediatric Patients.
    Mehrotra P; Jang J; Gidengil C; Sandora TJ
    Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
    Gabriel L; Beriot-Mathiot A
    J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D; Prabhu VS; Marcella SW
    Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of Clostridium difficile infection in pediatric operations: A propensity score-matching analysis.
    Kulaylat AN; Rocourt DV; Podany AB; Engbrecht BW; Twilley M; Santos MC; Cilley RE; Hollenbeak CS; Dillon PW
    Surgery; 2017 May; 161(5):1376-1386. PubMed ID: 28024858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating direct healthcare costs attributable to laboratory-confirmed Lyme disease in Ontario, Canada: A population-based matched cohort study using health administrative data.
    Shing E; Wang J; Khoo E; Evans GA; Moore S; Nelder MP; Patel SN; Russell C; Sider D; Sander B
    Zoonoses Public Health; 2019 Jun; 66(4):428-435. PubMed ID: 30665259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating Local Costs Associated With Clostridium difficile Infection Using Machine Learning and Electronic Medical Records.
    Pak TR; Chacko KI; O'Donnell T; Huprikar SS; van Bakel H; Kasarskis A; Scott ER
    Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1478-1486. PubMed ID: 29103378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study.
    Yu H; Baser O; Wang L
    BMC Geriatr; 2016 Nov; 16(1):193. PubMed ID: 27884118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
    Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of Clostridium difficile.
    McGlone SM; Bailey RR; Zimmer SM; Popovich MJ; Tian Y; Ufberg P; Muder RR; Lee BY
    Clin Microbiol Infect; 2012 Mar; 18(3):282-9. PubMed ID: 21668576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.
    Chen Y; Glass K; Liu B; Korda RJ; Riley TV; Kirk MD
    Am J Infect Control; 2017 May; 45(5):508-511. PubMed ID: 28089675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland.
    Robertson C; Pan J; Kavanagh K; Ford I; McCowan C; Bennie M; Marwick C; Leanord A
    J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
    van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
    J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.